These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12206039)

  • 21. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coverage and awareness of and compliance with mass drug administration for elimination of lymphatic filariasis in Burdwan District, West Bengal, India.
    Roy RN; Sarkar AP; Misra R; Chakroborty A; Mondal TK; Bag K
    J Health Popul Nutr; 2013 Jun; 31(2):171-7. PubMed ID: 23930334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effect of three different strategies for mass diethylcarbamazine administration in bancroftian filariasis: follow-up at 10 years after treatment.
    Meyrowitsch DW; Simonsen PE; Magesa SM
    Trans R Soc Trop Med Hyg; 2004 Nov; 98(11):627-34. PubMed ID: 15363642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage.
    Ramaiah KD; Vijay Kumar KN; Hosein E; Krishnamoorthy P; Augustin DJ; Snehalatha KS; Nanda B; Das PK
    Ann Trop Med Parasitol; 2006 Jun; 100(4):345-61. PubMed ID: 16762115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
    Lahariya C; Mishra A
    J Vector Borne Dis; 2008 Dec; 45(4):313-20. PubMed ID: 19248659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India.
    Yuvaraj J; Pani SP; Vanamail P; Ramaiah KD; Das PK
    Trop Med Int Health; 2008 May; 13(5):737-42. PubMed ID: 18346027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR; Taleo G; Toeaso V; Ichimori K
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of mass single-dose diethylcarbamazine and DEC-fortified salt against bancroftian filariasis in Papua New Guinea six months after treatment.
    Sapak P; Williams G; Bryan J; Riley I
    P N G Med J; 2000; 43(3-4):213-20. PubMed ID: 11939303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass administration of DEC-medicated salt for filariasis control in the endemic population of Karaikal, south India: implementation and impact assessment.
    Reddy GS; Venkateswaralu N
    Bull World Health Organ; 1996; 74(1):85-90. PubMed ID: 8653820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
    Krentel A; Fischer P; Manoempil P; Supali T; Servais G; Rückert P
    Trop Med Int Health; 2006 Nov; 11(11):1731-40. PubMed ID: 17054754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. India expands mass chemotherapy to eradicate filariasis.
    Sharma DC
    Lancet Infect Dis; 2004 Aug; 4(8):478. PubMed ID: 15298021
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.
    Vaishnav KG; Desai HS; Srivastava PK; Joshi PT; Kurian G; Thakor HG; Dhariwal AC
    J Commun Dis; 2012 Dec; 44(4):251-9. PubMed ID: 25145075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wuchereria bancrofti antigenemia clearance among Myanmar migrants after biannual mass treatments with diethylcarbamazine, 300 mg oral-dose FILADEC tablet, in Southern Thailand.
    Koyadun S; Bhumiratana A; Prikchu P
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):758-67. PubMed ID: 15115084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early development of acute filariasis in a migrant from non-endemic to hyper endemic area: a case report.
    Koya SM; Kumar S; Regu K; Sharma RC
    J Commun Dis; 1998 Jun; 30(2):117-20. PubMed ID: 9914679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse reactions of 300 MG diethylcarbamazine, and in a combination of 400 MG albendazole, for a mass annual single dose treatment, in migrant workers in Phang Nga province.
    Yongyuth P; Koyadun S; Jaturabundit N; Jariyahuttakij W; Bhumiratana A
    J Med Assoc Thai; 2007 Mar; 90(3):552-63. PubMed ID: 17427535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrastructural analysis of microfilariae of Wuchereria bancrofti obtained from persistent carriers after repeated courses of diethylcarbamazine.
    Alves LC; Cavalcanti MG; Araújo HR; Silva GM; Veras DL; Paiva MH; Brayner FA
    Micron; 2009; 40(5-6):659-64. PubMed ID: 19359187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy, tolerability and safety of diethylcarbamazine-fortified salt in the treatment of the microfilaraemias of brugian filariasis: an open, hospital-based study.
    Shenoy RK; Varghese J; Kuttikkal VV; Kumaraswami V
    Ann Trop Med Parasitol; 1998 Apr; 92(3):285-93. PubMed ID: 9713544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study on coverage, compliance and awareness about mass drug administration for elimination of lymphatic filariasis in a district of West Bengal, India.
    Karmakar PR; Mitra K; Chatterjee A; Jana PK; Bhattacharya S; Lahiri SK
    J Vector Borne Dis; 2011 Jun; 48(2):101-4. PubMed ID: 21715733
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenaemia.
    Simonsen PE; Magesa SM; Meyrowitsch DW; Malecela-Lazaro MN; Rwegoshora RT; Jaoko WG; Michael E
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):541-7. PubMed ID: 15869771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independent assessment of Mass Drug Administration in filariasis affected Surat city.
    Vaishnav KG; Patel IC
    J Commun Dis; 2006 Mar; 38(2):149-54. PubMed ID: 17370677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.